ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Current Quarter	$1.63	Next Quarter	$1.15
Current Year	$6.14	Next Year	$6.71
QoQ Growth	-29.4%	YoY Growth	+9.3%
3Y EPS CAGR	+32.6%	Target Price	$109.88
Consensus	Buy	Upside	+36.7%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ANIP	$80.39	-2.12%	413.11K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ANIP	$80.39	-2.1%	413.11K
3
4
5
6

ANIP

ANIP

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get ANI Pharmaceuticals Inc. Data in Excel

Get ANI Pharmaceuticals Inc. Data in Excel